Evidence map›Paper›PMID 36081553›Full record

ArticleFrontiers in oncology2022

Contrast-enhanced ultrasound of granular cell tumor in breast: A case report with review of the literature.

Huanyu Wang, Duo Feng, Tianhui Zou, Yao Liu, Xiaoqin Wu, Jiawei Zou, Rong Huang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Huanyu WangDepartment of Breast and Thyroid Surgery, Huazhong University of Science and Technology Shenzhen Union Hospital, Shenzhen, China.
Duo FengDepartment of Breast and Thyroid Surgery, Huazhong University of Science and Technology Shenzhen Union Hospital, Shenzhen, China.
Tianhui ZouDepartment of Breast and Thyroid Surgery, Huazhong University of Science and Technology Shenzhen Union Hospital, Shenzhen, China.
Yao LiuDepartment of Breast and Thyroid Surgery, Huazhong University of Science and Technology Shenzhen Union Hospital, Shenzhen, China.
Xiaoqin WuDepartment of Breast and Thyroid Surgery, Huazhong University of Science and Technology Shenzhen Union Hospital, Shenzhen, China.
Jiawei ZouDepartment of Breast and Thyroid Surgery, Huazhong University of Science and Technology Shenzhen Union Hospital, Shenzhen, China.
Rong HuangDepartment of Cardiology, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, China.
Union Hospital · CNHuazhong University of Science and Technology · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Granular cell tumor is an infrequent, predominantly benign tumor originating from Schwann cells. Granular cell tumor of the breast (GCTB) can simulate breast malignant carcinoma on the clinical assessment. We herein present a rare case of GCTB which recurred in the contralateral breast. We believe the contrast-enhanced ultrasound (CEUS) findings of GCTB have never been described. The high similarity of breast malignant carcinoma makes its differential diagnosis difficult on the clinical and radiological features. In this report, we present the CEUS findings from a rare case of GCTB, explore the possible value of CEUS in differential diagnosis between benign breast lesions and malignant ones, and briefly review the literature.

Indexed as

breast tumorcase reportContrast-enhanced ultrasounddiagnosesgranular cell tumor

Identifiers

PMID36081553
PMCPMC9445188
OpenAlexW4292834533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.